In the United States, FDA approved four-dose Mounjaro and Zepbound KwikPens on January 20, 2026, while single-dose Mounjaro and Zepbound pens and vials also remain in use
The rise in GLP-1 adoption is creating important shifts in consumer behavior
Although evidence of efficacy is lacking, the manufacturers claim improvement of melasma, hyperpigmentation and skin ageing
She specializes in integrative longevity medicine, combining evidence-based therapies like NAD+ IV therapy, peptide protocols, hormone optimization, and regenerative aesthetics
If your goals include general gut health support, mild inflammatory management, or you have needle phobia, oral formulations offer meaningful benefits with simpler administration
If you have diabetes and are already taking another drug, discuss acceptable (and safe) diabetes drug combinations with your doctor